HealthCare Global Enterprises Limited (NSE:HCG)
India · Delayed Price · Currency is INR 570.85
+5.30 (0.94%)
Nov 12, 2026, 3:29 PM IST
NSE:HCG Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, NSE:HCG stock has a consensus rating of "Strong Buy" and an average price target of ₹796.89. The average 1-year stock price forecast is 39.60% higher than the current stock price, while the lowest is ₹700.00 (+22.62%) and the highest is ₹920.00 (+61.16%).
Price Target: ₹796.89 (+39.60%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:HCG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 8 | 8 | 8 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Prabhudas Lilladher No rating | Prabhudas Lilladher | Buy Maintains ₹800.00 | Buy | Maintains | ₹800.00 | +40.14% | Nov 9, 2026 |
Financial Forecast
Revenue This Year
28.97B
from 25.45B
Increased by 13.80%
Revenue Next Year
33.22B
from 28.97B
Increased by 14.70%
EPS This Year
9.11
from 3.59
Increased by 153.70%
EPS Next Year
15.28
from 9.11
Increased by 67.63%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.